Current Vascular Pharmacology

Editor-in-Chief

Dimitri P. Mikhailidis
(33295 citations)
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street
London, NW3 2QG
(UK)

Personal Subscription
Become EABM
Become Reviewer

Articles Ahead of Print

Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients

Volume:19
Rigas G. Kalaitzidis*, Olga Balafa, Evangelia Dounousi, Dimitrios Stagikas and Vasilios Tsimihodimos

Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments

Volume:19
Vasilios G. Athyros*, Charalambos Koumaras and George Sfikas

Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways

Volume:19
Denise Coutinho de Miranda, Gabriela de Oliveira Faria, Milla Marques Hermidorff, Fernanda Cacilda dos Santos Silva, Leonardo Vinícius Monteiro de Assis and Mauro César Isoldi*

Cardioprotective Effects of Natural Products via the Nrf2 Signaling Pathway

Volume:19
Rasool Tavakoli, Jamshid Tabeshpour, Javad Asili, Abolfazl Shakeri* and Amirhossein Sahebkar

Diabetic Cardiomyopathy: Clinical and Metabolic Approach

Volume:19
Dragan B. Djordjevic*, Goran Koracevic, Aleksandar D. Djordjevic and Dragan B. Lovic*

Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Volume:18
Georgios Sfikas*, Michael Psallas, Charalambos Koumaras, Konstantinos Imprialos, Evangelos Perdikakis, Michael Doumas, Olga Giouleme, Asterios Karagiannis and Vasilios G. Athyros

Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Volume:18
Emir Muzurović*, Brigita Smolović, Snežana Vujošević and Milan Petakov

Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study

Volume:18
Silvia Lai*, Marco Mangiulli, Adolfo M Perrotta, Antonietta Gigante, Ludovica Napoleoni, Elena Cipolloni, Anna P Mitterhofer, Maria L Gasperini, Maurizio Muscaritoli, Rosario Cianci, Antonello Giovannetti, Fabiana Falco, Daniela Mastroluca and Sandro Mazzaferro

Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis

Volume:18
Marco De Carlo*, Giovanni Di Minno, Tobias Sayre, Mir Sohail Fazeli, Gaye Siliman and Claudio Cimminiello

Rationale and Design of the ACS-BP Study: Prognostic Value of In-Hospital Blood Pressure and Indices of Atherosclerosis in Acute Coronary Syndromes

Volume:18
Areti Koumelli , Konstantinos Konstantinou, Alexandros Kasiakogias, Kyriakos Dimitriadis, Ioannis Leontsinis , Emmanouil Mantzouranis , Elias Tolis, Christos Fragkoulis, Ioannis Ntalakouras, Costas Thomopoulos, Dimitrios Tousoulis and Costas Tsioufis*

PCSK9 Inhibitors and Ezetimibe Monotherapy in Patients Not Receiving Statins: A Meta-Analysis of Randomized Trials

Volume:18
Benjamin Benhuri, Hiroki Ueyama, Hisato Takagi, Alexandros Briasoulis and Toshiki Kuno*

Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class

Volume:18
Goran Koracevic , Sladjana Micic, Milovan Stojanovic *, Dragan Lovic, Dragan Simic , Mirko Colic , Maja Koracevic , Aleksandar Stojkovic and Milenko Paunovic

Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoprotein Cholesterol Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary Syndrome

Volume:18
Xiaohan Xu, Meng Chai, Yujing Cheng, Pingan Peng, Xiaoli Liu, Zhenxian Yan, Yonghe Guo, Yingxin Zhao and Yujie Zhou*

Comparison of Postprandial Serum Triglyceride and Apolipoprotein B Concentrations between the Two Phases of Menstrual Cycle in Healthy Women

Volume:18
Evangelia Tzeravini, Anastasios Tentolouris, Ioanna Eleftheriadou, Nikolaos Chaviaras, Genovefa Kolovou, Fani Apostolidou- Kiouti, Eleftherios Stratigakos and Nikolaos Tentolouris*

Paget’s Disease of Bone and Cardiovascular Risk: A Pilot Study

Volume:18
Agostino Gaudio*, Luca Zanoli, Anastasia Xourafa, Rosario Rapisarda, Antonino Catalano, Salvatore Santo Signorelli and Pietro Castellino

Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review

Volume:18
Xin Zhao, Jinfan Tian, Zhishuai Ye, Mingyue Xu, Xiantao Song* and Rongchong Huang

Effects of Gentiana lutea Root on Vascular Diseases

Volume:18
Gordana Joksic, Djordje Radak, Emina Sudar-Milovanovic, Milan Obradovic*, Jelena Radovanovic and Esma R. Isenovic

Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia

Volume:18
Vasilios G. Athyros, Chrysoula Boutari, Konstantinos Imprialos and Michael Doumas*

The Significance of Renal Function in Response to Cardiac Resynchronisation Therapy – A Piece of a Much Larger Puzzle

Volume:18
Agnieszka Dębska-Kozłowska, Izabela Warchoł, Marcin Książczyk* and Andrzej Lubiński

Novel Biomarkers/Predictors of Cardiovascular Disease and Cardiovascular Events

Volume:18
Kosmas I. Paraskevas*, Mateja K. Ježovnik and Pavel Poredoš